Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 5
Submit an article Journal homepage
1,126
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization

Fan ZhangDepartment of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University, Shanghai, People's Republic of ChinaView further author information
,
Junlan YangDepartment of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University, Shanghai, People's Republic of ChinaView further author information
,
Huafei LiDepartment of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University, Shanghai, People's Republic of ChinaView further author information
,
Moyan LiuDepartment of Nephrology, General Hospital of Jinan Military Command, Jinan, People's Republic of ChinaView further author information
,
Jie ZhangNursing Department, PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of ChinaView further author information
,
Lichao ZhaoMedical Department, General Hospital of Jinan Military Command, Jinan, ChinaView further author information
,
Lingxiong WangDepartment of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University, Shanghai, People's Republic of ChinaView further author information
,
RuiXia LingHuNational Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaView further author information
,
Fan FengDepartment of Pharmacy, General Hospital of Shenyang Military Command, Shenyang, People's Republic of ChinaView further author information
,
Xudong GaoDepartment of Gastroenterology, PLA 302 Hospital, Beijing, People's Republic of ChinaView further author information
,
Biqin DongDepartment of Physics, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Key Laboratory of Surface Physics, Fudan University, Shanghai, People's Republic of ChinaView further author information
,
Xiaohan LiuDepartment of Physics, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Key Laboratory of Surface Physics, Fudan University, Shanghai, People's Republic of ChinaView further author information
,
Jian ZiDepartment of Physics, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Key Laboratory of Surface Physics, Fudan University, Shanghai, People's Republic of ChinaView further author information
,
Weijing ZhangDepartment of Lymphoma, Affiliated Hospital of Academy of Military Medical Science, Beijing, People's Republic of ChinaView further author information
,
Yi HuDepartment of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University, Shanghai, People's Republic of ChinaView further author information
,
Jingkun PanNational Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaView further author information
,
Lei TianNational Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaView further author information
,
Yazuo HuNational Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaView further author information
,
Zhitao HanNational Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaView further author information
,
Honghong ZhangNational Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaView further author information
,
Xiaoning WangNational Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaCorrespondence[email protected]
View further author information
&
Lei ZhaoDepartment of Oncology, PLA General Hospital Cancer Center, PLA School of Medicine and Key Laboratory of Cell Engineering & Antibody, Beijing and Institute for Translational Medicine, Second Military Medical University, Shanghai, People's Republic of China;National Clinical Research Center for Normal Aging and Geriatric & Institute of Geriatric, PLA General Hospital and The Key Lab of Normal Aging and Geriatric, Beijing, People's Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: e1143995 | Received 21 Aug 2015, Accepted 13 Jan 2016, Published online: 31 May 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Du Meng, Ming Lei, Yaxuan Han, Dongli Zhao, Xiaozhi Zhang, Yunyi Yang & Rui Liu. (2018) MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells. OncoTargets and Therapy 11, pages 7733-7743.
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now
Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell & Lorenzo Galluzzi. (2017) Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. OncoImmunology 6:12.
Read now

Articles from other publishers (5)

Jeong Ryeol Kim, Donghyuk Lee, Yerim Kim & Joo Young Kim. (2022) CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma. Cancer Immunology, Immunotherapy 72:6, pages 1567-1580.
Crossref
Yang-Chi-Dung Lin, Hsi-Yuan Huang, Men-Yee Chiew, Chia-Hsin Hsu, Sirjana Shrestha, Meng-Chu Wu, Chen-Si Lin & Hsien-Da Huang. (2019) GENOME-WIDE METHYLOME ANALYSIS USING METHYLCAP-SEQ UNCOVERS NOVEL METHYLATED MARKERS FOR CANINE LYMPHOMA CELL LINE CLBL-1. Taiwan Veterinary Journal 45:04, pages 109-118.
Crossref
Qian Cheng, Xin Li, Yue Wang, Min Dong, Feng-huang Zhan & Jing Liu. (2017) The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro. Acta Pharmacologica Sinica 39:4, pages 561-568.
Crossref
Huabin Yin, Tong Meng, Ling Shu, Min Mao, Lei Zhou, Haiyan Chen & Dianwen Song. (2017) Novel reduction-sensitive micellar nanoparticles assembled from Rituximab-doxorubicin conjugates as smart and intuitive drug delivery systems for the treatment of non-Hodgkin's lymphoma. Chemical Biology & Drug Design 90:5, pages 892-899.
Crossref
Cong Wu, Wei Wan, Ji Zhu, Hai Jin, Tiejun Zhao & Huafei Li. (2017) Induction of potent apoptosis by an anti-CD20 aptamer via the crosslink of membrane CD20 on non-Hodgkin's lymphoma cells. RSC Advances 7:9, pages 5158-5166.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.